| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $523.8M | +26.1% |
| Cost of Revenue | $192.3M | +16.0% |
| Gross Profit | $331.5M | +32.9% |
| R&D Expense | $165.1M | +22.0% |
| SG&A Expense | $105.9M | +36.1% |
| Operating Income | -$177.4M | -24.0% |
| Pre-tax Income | -$170.6M | -19.3% |
| Income Tax | $4.7M | +122.0% |
| Net Income | -$175.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $320.8M | -44.7% |
| Short-term Investments | $459.7M | +90.6% |
| Accounts Receivable | $53.7M | +56.2% |
| Current Assets | $876.0M | -1.8% |
| Total Assets | $947.6M | -1.2% |
| Current Liabilities | $242.4M | +20.5% |
| Total Liabilities | $253.0M | +16.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.1M | -2279.3% |
| Investing Cash Flow | -$234.0M | -353.5% |
| Financing Cash Flow | $12.2M | -97.8% |
| -20.8% |
| EPS (Basic) | -$1.21 | +5.5% |
| EPS (Diluted) | -$1.21 | +5.5% |
| Stockholders' Equity |
| $694.6M |
| -6.3% |